Welcome to the fourteenth episode of Deciphering the virus.
After the arrival of the first Pfizer vaccines and Modern three months ago, again we are at a time where pharmaceutical companies have all the media focus, but for different reasons.
While the European Medicines Agency approved the Jansen’s vaccine, the first to be single-dose, doubts about the reliability of the once-expected European vaccination of Oxford y AstraZeneca they do not stop growing.
Nacho Alarcón. Brussels
–
Denmark announced that it was suspending its administration after detecting cases of thrombi that could be related to inoculation, one of them resulting in death. A temporary suspension but that has generated a call effect causing partial or total suspensions throughout Europe.
Also, in the ‘current paper, our chief virologist Estanislao Nistal Villán brings us an article of a comparative study carried out in Israel, the country with most vaccinated population in the world, where more than a million and a half people from different groups have been compared to determine the immune efficacy of those inoculated with the Pfizer vaccine.
Europa Press
–
To discuss these and other issues we have as a guest Quique Bassat, pediatrician and epidemiologist from the Barcelona Institute of Global Health (ISGlobal), who will be accompanied by the scientists Estanislao Nistal-Villán and Juan José López-Moya and the journalists of El Confidencial, Antonio Villarreal Y Angel Villarino.
If you prefer the ‘podcast’ format, you can follow the program on the following platforms:
Ivoox: https://go.ivoox.com/rf/66746168
Spotify: https://open.spotify.com/show/77AVY1hv4jl9g0IQS7XlR4
Do not forget that, if you want to see more videos like this, you can visit and subscribe here to our YouTube channel.
–
